drugset / Trial / NCT04431141

Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin

NCT04431141

Phase 1 Completed 32 enrolled Handok Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This study is to evaluate pharmacokinetic drug interaction between teneligliptin and empagliflozin in healthy adults.

Timeline

Start
2020-09-15
Primary completion
2020-11-16
Completion
2021-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule
Subject Teneligliptin Small molecule